Axon Enterprise, Inc. (NASDAQ:AXON) Director Sells $639,690.00 in Stock

Axon Enterprise, Inc. (NASDAQ:AXON) Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $639.69, for a total transaction of $639,690.00. Following the transaction, the director now owns 24,259 shares of the company’s stock, valued at $15,518,239.71. This represents a 3.96 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Michael Garnreiter also recently made the following trade(s):

• On Tuesday, October 15th, Michael Garnreiter sold 1,000 shares of Axon Enterprise stock. The shares were sold at an average price of $437.98, for a total transaction of $437,980.00.

Axon Enterprise Stock Down 4.1 %

AXON opened at $609.96 on Thursday. Axon Enterprise, Inc. has a twelve month low of $241.72 and a twelve month high of $698.67. The company’s 50-day moving average price is $551.82 and its two-hundred day moving average price is $412.77. The stock has a market cap of $46.51 billion, a price-to-earnings ratio of 157.61, a PEG ratio of 14.19 and a beta of 1.01. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Analyst Ratings Changes

Several analysts have recently commented on AXON shares. Robert W. Baird increased their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Northland Securities increased their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. The Goldman Sachs Group lifted their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. JMP Securities increased their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. Finally, Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. One research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $488.67.

Institutional Investors Weigh In On Axon Enterprise

A number of hedge funds have recently modified their holdings of AXON. Brass Tax Wealth Management Inc. purchased a new stake in Axon Enterprise in the third quarter worth $240,000. Oddo BHF Asset Management Sas purchased a new stake in Axon Enterprise in the 3rd quarter worth about $1,522,000. Denver PWM LLC raised its stake in Axon Enterprise by 69.7% in the 3rd quarter. Denver PWM LLC now owns 414 shares of the biotechnology company’s stock valued at $165,000 after acquiring an additional 170 shares during the period. Tidal Investments LLC lifted its holdings in Axon Enterprise by 13.8% during the third quarter. Tidal Investments LLC now owns 3,250 shares of the biotechnology company’s stock valued at $1,299,000 after purchasing an additional 394 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB bought a new position in Axon Enterprise during the third quarter worth about $759,000. Institutional investors own 79.08% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.